Shenzhen Transsion Holdings Co Ltd (688036)
Shanghai Stock Exchange · China · prices in CNY · close of 23 Oct 2026
Key indicators
| Last close | CNY 59.11 |
|---|---|
| 52-week range | 45.26 – 78.07 |
| Return, 1 month / 3 months | +6.2% / −4.3% |
| Return, 1 year / 3 years | −23.7% / −56.1% |
| Trend | Uptrend |
| RSI (14) | 64 |
| Volatility (1 year) | 49.8% |
| Worst drawdown (1 year) | -47.4% |
| Average daily value traded | 777.87M CNY |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Shenzhen Transsion Holdings designs and makes mobile phones, including smartphones and basic handsets, under brands such as Tecno, Infinix and itel. Its customers are mainly consumers in emerging markets, particularly across Africa, where its phones are widely used, and it also offers accessories and after-sales services. The company is based in Shenzhen, China, and its products are built for affordability and for local needs such as long battery life and support for multiple SIM cards.
On this site Shenzhen Transsion Holdings Co Ltd appears as a stock on the Shanghai Stock Exchange (China), code 688036, with prices in Chinese yuan (CNY). Our dividend records, which start in 2019, show payments in 4 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Shenzhen Transsion Holdings Co Ltd (688036) trades on the Shanghai Stock Exchange in China. It last closed at CNY 59.11 on 23 October 2026.
Its price-based Market X-Ray is 60 out of 100 (a fair price profile), ranking 653 of 2,278 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 23.7% and over the last three months it fell 4.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Shanghai Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 76 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 1.6% | ||
| From 52-week high | -24.0% | ||
| Momentum | 48 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -4.3% | ||
| 6-month return | 8.5% | ||
| 12-month return, skipping the last month | -28.2% | ||
| Stability (higher is calmer) | 40 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 49.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -47.4% | ||
| Liquidity | 89 · Strong | Trades actively. | |
| Average daily value traded | 777.87M CNY | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 2 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Liquidity: Trades actively.
Weak spots
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +22.8% |
|---|---|
| 1 month | +6.2% |
| 3 months | −4.3% |
| 6 months | +8.5% |
| 1 year | −23.7% |
| 3 years | −56.1% |
| 5 years | −57.5% |
Signals
| 50-day / 200-day average | 54.39 / 58.16 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 2.61 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 31 May 2023 | CNY 1.8000 |
| 23 Jun 2022 | CNY 1.5000 |
| 11 Jun 2021 | CNY 1.0800 |
| 11 Jun 2020 | CNY 0.6800 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Shanghai Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.